x

ACELYRIN, Inc. (Nasdaq:SLRN)

Health Care/Life Sciences • Biotechnology
CIK 1962918
Company

ACELYRIN, Inc. operates as a biopharma company. It engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company was founded by Shao-Lee Lin on July 27, 2020 and is headquartered in Agoura Hills, CA.

Address
4149 Liberty Canyon Road
Agoura Hills, California 91301
Employees
51
Stock Info
Close
$8.09
Day Range
7.41 - 8.32
52 Week Range
5.70 - 29.88
Average volume
1.11M
Short Interest
6.69M (02/15/24)
% of Float Shorted
11.10%
Market Cap
$802.08M
Revenue
N/A
Net Income
-$64.77M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$3.10
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman
Bruce C Cozadd MBA
Chief Executive Officer & Director
Shao Lee Lin MD, PhD
Director
Henry O Gosebruch CPA
Director
Dawn A Svoronos
Director
Lynn A Tetrault
Director
Clarence Patrick Machado
Director
Beth C Seidenberg MD
Director
Alan B Colowick MD
Director
Dan Becker MD, PhD
SEC filings
DateFormEvent
10 Dec, 2024 8-K
27 Nov, 2024 4
22 Nov, 2024 3
22 Nov, 2024 EFFECT
14 Nov, 2024 SC 13G/A
13 Nov, 2024 10-Q
13 Nov, 2024 8-K
13 Nov, 2024 8-K
13 Nov, 2024 S-3
12 Nov, 2024 SC 13G/A
8 Nov, 2024 SC 13G
4 Nov, 2024 SC 13G
4 Nov, 2024 8-K/A
24 Oct, 2024 SC 13G
10 Sep, 2024 SC 13G
4 Sep, 2024 4
13 Aug, 2024 8-K
13 Aug, 2024 10-Q
12 Aug, 2024 SC 13G/A
19 Jul, 2024 4
11 Jun, 2024 4
11 Jun, 2024 4
11 Jun, 2024 4
11 Jun, 2024 4
11 Jun, 2024 4
11 Jun, 2024 4
11 Jun, 2024 4
11 Jun, 2024 8-K
28 May, 2024 4
28 May, 2024 8-K/A
24 May, 2024 4
24 May, 2024 4
24 May, 2024 4
24 May, 2024 4
20 May, 2024 SC 13G
17 May, 2024 4
17 May, 2024 3
17 May, 2024 3
17 May, 2024 4
17 May, 2024 4
14 May, 2024 10-Q
9 May, 2024 8-K
9 May, 2024 DEFA14A
22 Apr, 2024 ARS
22 Apr, 2024 DEF 14A
22 Apr, 2024 DEFA14A
19 Apr, 2024 SC 13G
3 Apr, 2024 4
28 Mar, 2024 8-K
28 Mar, 2024 10-K
28 Mar, 2024 S-8
28 Mar, 2024 SC 13G
20 Mar, 2024 144
20 Mar, 2024 8-K
11 Mar, 2024 8-K
22 Feb, 2024 4
14 Feb, 2024 SC 13G/A
13 Feb, 2024 SC 13G
9 Feb, 2024 SC 13G/A
11 Jan, 2024 4
11 Jan, 2024 4
11 Jan, 2024 4
11 Jan, 2024 4
11 Jan, 2024 4
4 Jan, 2024 4
20 Dec, 2023 3
20 Dec, 2023 8-K
20 Dec, 2023 4
27 Nov, 2023 8-K
9 Nov, 2023 10-Q
7 Nov, 2023 8-K
13 Oct, 2023 SC 13G
10 Oct, 2023 SC 13G
6 Oct, 2023 4
6 Oct, 2023 4
6 Oct, 2023 4
6 Oct, 2023 4
21 Aug, 2023 8-K
21 Aug, 2023 4
18 Aug, 2023 4
18 Aug, 2023 4
18 Aug, 2023 4
18 Aug, 2023 4
18 Aug, 2023 4
14 Aug, 2023 10-Q
14 Aug, 2023 8-K
3 Aug, 2023 3
2 Aug, 2023 8-K
15 Jun, 2023 10-Q
15 Jun, 2023 8-K
19 May, 2023 SC 13D
19 May, 2023 SC 13D
19 May, 2023 SC 13G
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
9 May, 2023 8-K
8 May, 2023 S-8
5 May, 2023 424B4 IPO completed
4 May, 2023 4
4 May, 2023 4
4 May, 2023 4
4 May, 2023 4
4 May, 2023 4
4 May, 2023 4
4 May, 2023 4
4 May, 2023 4
4 May, 2023 CERT
4 May, 2023 S-1MEF
4 May, 2023 3
4 May, 2023 SEC STAFF
4 May, 2023 3
4 May, 2023 4
4 May, 2023 4
4 May, 2023 3
4 May, 2023 3
4 May, 2023 3
4 May, 2023 3
4 May, 2023 3
4 May, 2023 3
4 May, 2023 EFFECT
4 May, 2023 4
4 May, 2023 3
4 May, 2023 3
4 May, 2023 3
4 May, 2023 3
4 May, 2023 3
4 May, 2023 3
4 May, 2023 3
3 May, 2023 S-1/A
2 May, 2023 CORRESP
2 May, 2023 CORRESP
2 May, 2023 8-A12B
1 May, 2023 S-1/A
20 Apr, 2023 CORRESP
13 Apr, 2023 CORRESP
13 Apr, 2023 S-1
6 Apr, 2023 UPLOAD
3 Apr, 2023 SEC STAFF
24 Mar, 2023 DRS/A
24 Mar, 2023 DRSLTR
15 Mar, 2023 UPLOAD
10 Feb, 2023 DRS
Last update:2024-03-06 12:29:50.155071
ACELYRIN, Inc. by TradingView

Sign Up to Subscribe